Filing Details
- Accession Number:
- 0001225208-16-026014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-10 17:45:15
- Reporting Period:
- 2016-02-08
- Filing Date:
- 2016-02-10
- Accepted Time:
- 2016-02-10 17:45:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204663 | H John Weiland | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | President And Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-02-08 | 5,433 | $179.81 | 61,976 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2016-02-09 | 699 | $182.48 | 61,277 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-02-09 | 2,208 | $181.78 | 59,069 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-02-09 | 5,991 | $180.69 | 53,078 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,864 | Indirect | 401(k) Plan |
Footnotes
- Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program.
- Sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $182.35 to $182.69. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $181.29 to $182.27. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $180.26 to $181.14. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Includes 32.702 shares acquired under the Company's 401(k) Plan from November 7, 2015 to February 5, 2016.
Billionaire Hedge Funds
